Zobrazeno 1 - 10
of 177
pro vyhledávání: '"T, Vietti"'
Autor:
E Greaves, R Allison, V Datton, Archie Bleyer, A Reiter, Harland N. Sather, S Murphy, C P Steuber, M F Auclerc, E C GordonSmith, Indraneel Mittra, Colin Baigent, A Solidoro, M Donnelly, Michael L. Hancock, M Cairo, D Sinclair, E Lepage, P A Shetty, C Harwood, Andrea Pession, R. D. Gelber, T Vietti, A Bancillon, D Mahoney, Richard Peto, V J Land, Santarelli, F SackmanMuriel, Maria Grazia Valsecchi, Giuseppe Masera, Mike Clarke, H Riehm, Richard Gray, C Perez, W Crist, H Duong, Michael E. Trigg, O R McIntyre, J Simone, Ching-Hon Pui, Jon Godwin, Paul S. Gaynon, Julian Peto, L Clavell, Keith Wheatley, J Chessells, Stephen E. Sallan, Martin Schrappe, O B Eden, S Richards, Roberto Rondelli, J Durrant, C Bailey, J Lilleyman, A Burnett, G Schaison, Gregory H. Reaman
Publikováno v:
The Lancet. 347:1783-1788
The effects on long-term outcome in childhood acute lymphoblastic leukaemia (ALL) of the duration and the intensity of maintenance chemotherapy need to be assessed reliably. With this objective the Childhood ALL Collaborative Group coordinated a worl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f3b89bdfe5c7a3da7e5c82d96fdbbc1
https://doi.org/10.1016/s0140-6736(96)91615-3
https://doi.org/10.1016/s0140-6736(96)91615-3
Autor:
M, Deutsch, P R, Thomas, J, Krischer, J M, Boyett, L, Albright, P, Aronin, J, Langston, J C, Allen, R J, Packer, R, Linggood, R, Mulhern, P, Stanley, J A, Stehbens, P, Duffner, L, Kun, L, Rorke, J, Cherlow, H, Freidman, J L, Finlay, T, Vietti
Publikováno v:
Pediatric neurosurgery. 24(4)
To determine in a prospective randomized trial the effect on survival, progression-free survival, and patterns of relapse of a decrease in the neuraxis radiation dose from 3,600 cGy in 20 fractions to 2,340 cGy in 13 fractions in patients with newly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27cd46ded8793bde7a1846077ba6897e
https://pubmed.ncbi.nlm.nih.gov/8873158
https://pubmed.ncbi.nlm.nih.gov/8873158
Autor:
Y. Ravindranath, C. P. Steuber, M. Gresik, C. Civin, Jeffrey P. Krischer, Howard J. Weinstein, T. Vietti
Publikováno v:
Haematology and Blood Transfusion / Hämatologie und Bluttransfusion ISBN: 9783642783524
During the past decade, the Pediatric Oncology Group (POG) clinical trials for childhood acute myelogenous leukemia (AML) have focused on the early phases of treatment since the median time to relapse tends to occur within the first six to nine month
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0079f87e8212a4ad67801efb632f6ea
https://doi.org/10.1007/978-3-642-78350-0_84
https://doi.org/10.1007/978-3-642-78350-0_84
Publikováno v:
Leukemia. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c706c42d5099ff8048b7e1b20f857ba7
https://pubmed.ncbi.nlm.nih.gov/1578941
https://pubmed.ncbi.nlm.nih.gov/1578941
Autor:
W Crist, J Boyett, M Roper, J Pullen, R Metzgar, J van Eys, A Ragab, K Starling, T Vietti, M Cooper
Publikováno v:
Blood. 63:407-414
Seventy-eight of 362 children with acute lymphocytic leukemia (ALL) had leukemic cells similar in phenotype to normal pre-B cells. When the clinical and laboratory features of patients with pre-B and “null” cell phenotypes of ALL were compared, n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::562e5f2266d08eaa5a7571bd39bd723a
https://doi.org/10.1182/blood.v63.2.407.bloodjournal632407
https://doi.org/10.1182/blood.v63.2.407.bloodjournal632407
Autor:
T. Vietti, Abdelsalam H. Ragab, J. Pullen, W. Crist, Max D. Cooper, K. Starling, J. Boyett, R. Metzgar, M. Roper, J van Eys
Publikováno v:
Blood. 63:407-414
Seventy-eight of 362 children with acute lymphocytic leukemia (ALL) had leukemic cells similar in phenotype to normal pre-B cells. When the clinical and laboratory features of patients with pre-B and “null” cell phenotypes of ALL were compared, n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f393840d1392706e0589eafbe9e009c0
https://doi.org/10.1182/blood.v63.2.407.407
https://doi.org/10.1182/blood.v63.2.407.407
Autor:
W Crist, J Boyett, J Jackson, T Vietti, M Borowitz, A Chauvenet, N Winick, A Ragab, D Mahoney, D Head
Publikováno v:
Blood. 74:1252-1259
We report the prognostic significance of the pre-B-cell immunophenotype and other presenting features, including blast cell karyotype, in a randomized clinical trial conducted from 1981 to 1986 for children with early pre-B (n = 685) or pre-B (n = 22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de76fb1913a189896e16b51916e383df
https://doi.org/10.1182/blood.v74.4.1252.1252
https://doi.org/10.1182/blood.v74.4.1252.1252
Publikováno v:
Cancer. 29:1057-1060
Seventeen children with acute myelocytic leukemia were treated with a combination of 6-azauridine, 6-mercaptopurine, and vincristine. Twelve attained complete bone marrow remission, and 2 achieved good partial remissions. For maintenance therapy, pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cec3469a7555336a1e11061efa6a528
https://doi.org/10.1002/1097-0142(197204)29:4<1057::aid-cncr2820290455>3.0.co
https://doi.org/10.1002/1097-0142(197204)29:4<1057::aid-cncr2820290455>3.0.co
Publikováno v:
Cancer research. 35(6)
Although both 1-beta-D-arabinofuranosylcytosine (ara-C) and methotrexate are presumed to be toxic as a result of their interference with DNA synthesis, results obtained with L1210 cells in vivo suggest that the combination of ara-C and methotrexate i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bae4d37e488f49353ed8b40dca19a1e9
https://pubmed.ncbi.nlm.nih.gov/1131822
https://pubmed.ncbi.nlm.nih.gov/1131822
Publikováno v:
Cancer research. 34(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa057acbd270404a4daf629c1c9bab92
https://pubmed.ncbi.nlm.nih.gov/4842737
https://pubmed.ncbi.nlm.nih.gov/4842737